Use of inhaled corticosteroids and risk of fractures

Journal of Bone and Mineral Research

Volumn 16, Issue 3, 2001, Pages 581-588

  Van Staa, T P ^a,b,c   Leufkens, H G M ^a   Cooper, C ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Corticosteroid; Epidemiology; Fracture; Inhaled; Osteoporosis

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM; VERTEBRA FRACTURE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; AIRWAY OBSTRUCTION; ASTHMA; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035101831     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.3.581     Document Type: Article

References (50)

1. Inhaled glucocorticoids for asthma
2. The British guidelines on asthma management
3. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
4. Systemic adverse effects of inhaled corticosteroid therapy
5. Use of oral corticosteroids and risk of fractures
6. Effects on bone are unlikely with low to moderate dosages: Do inhaled steroids cause osteoporosis?
7. Effects on inhaled corticosteroids on bone density and metabolism
8. Effects on long-term use of high-dose inhaled steroids on bone density and calcium metabolism
9. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids
10. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
11. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids
12. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: A case-control study
13. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids
14. Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis and polymyalgia rheumatica
15. Bone mineral density in women taking inhaled corticosteroids
16. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma
17. Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma
18. Effect of inhaled corticosteroid on bone density in asthmatic patients: A pilot study
19. Inhaled corticosteroid use and bone mineral density in patients with asthma
20. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary, disease
21. Crippling consequences of fractures and their impact on quality of life
22. Pharmacoepidemiology using a UK Database of Primary Care Records
23. The Vamp Research multi-purpose Database in the UK
24. Research implications of computerised primary care
25. The UK General Practice Research Database
26. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
27. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom
28. Accuracy of diagnosis of psychosis on general practice computer system
29. The quality of information recorded on a UK database of primary care records: A study of hospitalization due to hypoglycemia and other conditions
30. The role of a second control group in an observational study
31. Osteoporosis associated with illness and medications
32. Falls as risk factors for fractures
33. Bone turnover during high-dose inhaled corticosteroid therapy
34. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate
35. Effect of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women
36. Comparison of long-term safety and efficacy of fluticasone propionate in combination with salmeterol in patients with moderate to severe asthma
37. A randomised double blind trial comparing effects of beclomethasone dipropionate 2000/day versus fluticasone propionate 1000/day on bone density over 2 years
38. Theophylline-induced hypercalcemia
39. Effects of theophylline on urinary excretion of cyclic AMP, calcium and phosphorus in normal subjects
40. Intravenous aminophylline and osteoporosis
41. Risk of osteoporosis in men with chronic bronchitis
42. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease
43. Risk fractures for osteoporotic fracture
44. Falls as risk factors for fractures